Q: What is Praluent used for?

Praluent is used to treat: Primary hyperlipidemia Homozygous familial hypercholesterolemia Reduction of cardiovascular risk

Q: How does Praluent work?

Mechanism of Action Praluent belongs to a class of drugs known as PCSK9 inhibitors. It works by targeting and blocking a protein in the liver called proprotein convertase subtilisin/kexin type 9 (PCSK9). To understand how Praluent works, it is helpful to look at how the body naturally manages cholesterol: LDL Receptors: The liver has receptors on its surface that act like magnets to pull LDL (bad) cholesterol out of the bloodstream so it can be broken down and removed from the body. The Role of PCSK9: The PCSK9 protein normally binds to these LDL receptors and causes them to be broken down. When these receptors are destroyed, the liver cannot remove as much cholesterol, leading to higher levels of LDL in the blood. Praluent attaches to the PCSK9 protein and prevents it from binding to the LDL receptors. By blocking this protein, the medication allows more receptors to remain active on the surface of the liver. These additional receptors can then capture and clear more LDL cholesterol from the blood, which lowers the overall level of circulating cholesterol.

Q: What are the active ingredients in Praluent?

The active ingredient in Praluent is alirocumab .

Q: What are the side effects of Praluent?

Common side effects of Praluent may include: injection site reactions nasopharyngitis influenza Always consult with a healthcare professional about potential side effects.

Q: What drug class is Praluent?

Praluent belongs to the PCSK9 inhibitor drug class.

Q: What is the dosage of Praluent and how do I take it?

Administration Instructions Praluent is given as a subcutaneous injection. Common injection sites include the thigh, abdomen, or upper arm. It is important to use a different injection site each time you administer the medication to reduce the risk of skin irritation. Before use, take the medication out of the refrigerator and let it reach room temperature. Do not shake the pre-filled pen or syringe. Inspect the liquid before injecting; it should be clear and colorless to pale yellow. Do not use the medication if it appears cloudy, contains particles, or is discolored. Dosing Schedule This medication is generally used once every two weeks or once every four weeks. Your healthcare provider will determine the appropriate schedule for your condition. It is important to use the medication exactly as directed and on the same day of the week or month as scheduled. Missed Dose If you miss a dose, use it as soon as you remember. However, if too much time has passed since the scheduled dose, you may need to skip the missed dose or adjust your future dosing schedule. Consult the patient information leaflet or your healthcare provider for specific instructions on how to proceed based on your prescribed schedule.

Q: Is Praluent safe during pregnancy and breastfeeding?

Pregnancy There is limited information available regarding the safety of Praluent use during pregnancy. While animal studies did not indicate direct harm to the fetus, monoclonal antibodies such as Praluent are known to cross the placenta, particularly during the second and third trimesters. The potential risk to a human fetus is not fully understood. If you are pregnant or planning to become pregnant, discuss the risks and benefits of this medication with your healthcare provider. They will determine if the treatment is appropriate for your specific medical needs during pregnancy. Breastfeeding It is not known if Praluent passes into human breast milk or if it could affect a breastfeeding child. Because many drugs are present in human milk, healthcare providers typically advise caution. If you are breastfeeding or planning to breastfeed, talk to your doctor. You will need to weigh the benefits of the medication for your health against the potential risks to your nursing infant.

Q: What is the FDA approval status of Praluent?

FDA Approval and Indications Praluent (alirocumab) received its initial approval from the U.S. Food and Drug Administration (FDA) in 2015. It belongs to a class of drugs known as PCSK9 inhibitors. The FDA has approved Praluent for the following indications in adults: To reduce the risk of heart attack, stroke, and unstable angina requiring hospitalization in adults with established cardiovascular disease. To be used in combination with diet, either alone or with other lipid-lowering therapies, for the treatment of primary hyperlipidemia (including heterozygous familial hypercholesterolemia) to reduce low-density lipoprotein (LDL) cholesterol. To reduce LDL cholesterol in adults with homozygous familial hypercholesterolemia. Safety and Monitoring There are currently no boxed warnings or Risk Evaluation and Mitigation Strategies (REMS) required by the FDA for this medication. Regulatory approval was based on clinical evidence showing the drug's ability to significantly lower LDL cholesterol levels and reduce the incidence of major adverse cardiovascular events when used as directed.

Question 1

What is Praluent?

Accepted Answer

Praluent is a monoclonal antibody that functions as a PCSK9 inhibitor. It works by blocking a specific protein in the liver, which allows the body to more effectively remove low-density lipoprotein (LDL) cholesterol from the blood.

By increasing the liver's ability to process and eliminate this cholesterol, the medication helps reduce the total amount of bad cholesterol circulating in the bloodstream.

Question 2

What is Praluent used for?

Accepted Answer

Praluent is used to treat:

Primary hyperlipidemia
Homozygous familial hypercholesterolemia
Reduction of cardiovascular risk

Question 3

How does Praluent work?

Accepted Answer

Mechanism of Action

Praluent belongs to a class of drugs known as PCSK9 inhibitors. It works by targeting and blocking a protein in the liver called proprotein convertase subtilisin/kexin type 9 (PCSK9).

To understand how Praluent works, it is helpful to look at how the body naturally manages cholesterol:

LDL Receptors: The liver has receptors on its surface that act like magnets to pull LDL (bad) cholesterol out of the bloodstream so it can be broken down and removed from the body.
The Role of PCSK9: The PCSK9 protein normally binds to these LDL receptors and causes them to be broken down. When these receptors are destroyed, the liver cannot remove as much cholesterol, leading to higher levels of LDL in the blood.

Praluent attaches to the PCSK9 protein and prevents it from binding to the LDL receptors. By blocking this protein, the medication allows more receptors to remain active on the surface of the liver. These additional receptors can then capture and clear more LDL cholesterol from the blood, which lowers the overall level of circulating cholesterol.

Question 4

What are the active ingredients in Praluent?

Accepted Answer

The active ingredient in Praluent is alirocumab.

Question 5

What are the side effects of Praluent?

Accepted Answer

Common side effects of Praluent may include:

injection site reactions
nasopharyngitis
influenza

Always consult with a healthcare professional about potential side effects.

Question 6

What drug class is Praluent?

Accepted Answer

Praluent belongs to the PCSK9 inhibitor drug class.

Question 7

What is the dosage of Praluent and how do I take it?

Accepted Answer

Administration Instructions

Praluent is given as a subcutaneous injection. Common injection sites include the thigh, abdomen, or upper arm. It is important to use a different injection site each time you administer the medication to reduce the risk of skin irritation.

Before use, take the medication out of the refrigerator and let it reach room temperature. Do not shake the pre-filled pen or syringe. Inspect the liquid before injecting; it should be clear and colorless to pale yellow. Do not use the medication if it appears cloudy, contains particles, or is discolored.

Dosing Schedule

This medication is generally used once every two weeks or once every four weeks. Your healthcare provider will determine the appropriate schedule for your condition. It is important to use the medication exactly as directed and on the same day of the week or month as scheduled.

Missed Dose

If you miss a dose, use it as soon as you remember. However, if too much time has passed since the scheduled dose, you may need to skip the missed dose or adjust your future dosing schedule. Consult the patient information leaflet or your healthcare provider for specific instructions on how to proceed based on your prescribed schedule.

Question 8

Is Praluent safe during pregnancy and breastfeeding?

Accepted Answer

Pregnancy

There is limited information available regarding the safety of Praluent use during pregnancy. While animal studies did not indicate direct harm to the fetus, monoclonal antibodies such as Praluent are known to cross the placenta, particularly during the second and third trimesters. The potential risk to a human fetus is not fully understood.

If you are pregnant or planning to become pregnant, discuss the risks and benefits of this medication with your healthcare provider. They will determine if the treatment is appropriate for your specific medical needs during pregnancy.

Breastfeeding

It is not known if Praluent passes into human breast milk or if it could affect a breastfeeding child. Because many drugs are present in human milk, healthcare providers typically advise caution.

If you are breastfeeding or planning to breastfeed, talk to your doctor. You will need to weigh the benefits of the medication for your health against the potential risks to your nursing infant.

Question 9

What forms and strengths does Praluent come in?

Accepted Answer

Praluent is supplied as a sterile, preservative-free liquid solution. It is available in the following delivery formats:

Single-dose pre-filled pen: A disposable device designed for self-administration.
Single-dose pre-filled syringe: A disposable syringe containing a fixed dose of the medication.

The solution is typically clear and colorless to pale yellow. These forms are intended for subcutaneous injection only, meaning they are injected into the fatty tissue just beneath the skin.

Question 10

What is the FDA approval status of Praluent?

Accepted Answer

FDA Approval and Indications

Praluent (alirocumab) received its initial approval from the U.S. Food and Drug Administration (FDA) in 2015. It belongs to a class of drugs known as PCSK9 inhibitors.

The FDA has approved Praluent for the following indications in adults:

To reduce the risk of heart attack, stroke, and unstable angina requiring hospitalization in adults with established cardiovascular disease.
To be used in combination with diet, either alone or with other lipid-lowering therapies, for the treatment of primary hyperlipidemia (including heterozygous familial hypercholesterolemia) to reduce low-density lipoprotein (LDL) cholesterol.
To reduce LDL cholesterol in adults with homozygous familial hypercholesterolemia.

Safety and Monitoring

There are currently no boxed warnings or Risk Evaluation and Mitigation Strategies (REMS) required by the FDA for this medication. Regulatory approval was based on clinical evidence showing the drug's ability to significantly lower LDL cholesterol levels and reduce the incidence of major adverse cardiovascular events when used as directed.

Question 11

What should I know about Praluent and cost?

Accepted Answer

Factors Influencing Cost

The price of Praluent can vary based on several factors, including your specific insurance plan, the pharmacy you visit, and whether you qualify for cost-saving programs.

Generic and Biosimilar Status

Praluent is a brand-name medication and is not currently available in a generic or biosimilar form. Biologic drugs like Praluent are often more expensive than traditional medications because of the complex manufacturing processes required.

Insurance and Prior Authorization

Insurance companies often require prior authorization before they will cover Praluent. This means your healthcare provider must submit a request to your insurance company to prove that the medication is medically necessary for your condition.

Financial Assistance Programs

Financial assistance may be available through the manufacturer for eligible patients. This can include copay cards for those with commercial insurance or patient assistance programs for individuals who are uninsured or have limited coverage.

Praluent

📋Overview

How It Works

Uses

Active Ingredients

Common Side Effects

Warnings & Precautions

Dosage

Pregnancy & Breastfeeding

Frequently Asked Questions

📚References

Found an Error?

Find Discounts for Praluent

Hospitals.net Disclosure